(S)-3-Amino-4-(2,4-dichlorophenyl)butanoic acid hydrochloride is primarily utilized in the field of pharmaceutical research and development. It serves as a key intermediate in the synthesis of various biologically active compounds, particularly those targeting neurological and psychiatric disorders. Its structural properties make it valuable in the design of drugs that interact with specific receptors or enzymes in the brain, potentially aiding in the treatment of conditions such as anxiety, depression, or epilepsy. Additionally, it may be explored for its role in modulating neurotransmitter systems, contributing to the advancement of therapies for central nervous system-related diseases. Researchers also investigate its potential in creating enantiomerically pure compounds, ensuring higher efficacy and reduced side effects in drug formulations.